Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it
Maintaining weight loss after medication ends is a difficult transition, prompting researchers to test two practical support options…
Stevia tastes sweet, but does your body react as if sugar is coming?
Researchers tested stevia alone and alongside glucose across three metabolic groups to see whether sweetness with little or…
Semaglutide did more than cut weight in this analysis of 6,239 adults
A meta-analysis of more than 6,000 adults reveals how semaglutide affects weight and key metabolic markers, while new…
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Tennis legend Serena Williams is speaking openly about her decision to use a GLP-1 weight-loss medication, adding her…
GLP-1s not a ‘lifestyle product’ – The Star
GLP-1s not a ‘lifestyle product’ The StarCalls to poison centers skyrocket amid rise in use of GLP-1 drugs, experts…
Protein craze can lead to better health if done right
It’s a question that Dr. Travis Wilkes gets asked every day by patients. It is something that Dr.…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
Lost weight is less likely to return when exercise follows obesity treatment
Exercise may offer a modest but measurable defense against weight regain after dieting or bariatric surgery, but the…
Regulators issue warning on ads for unlicensed weight loss drugs – Chemist+Druggist
Regulators issue warning on ads for unlicensed weight loss drugs Chemist+DruggistWegovy GLP-1 pill could reshape Britain’s £220bn food market,…
Walking 6K, 12K or 18K steps a day? Fitness coach reveals how many pounds of fat you could lose
If you’re looking for a sustainable way to lose weight, the answer could be as simple as putting…
Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…